Cambridge Healthtech Institute

Transcription

1 Cambridge Healthtech Institute Your Life Science Network Conference & Course Catalog August 2015 February 2016 Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA T: (781) or Toll-free in the U.S F: (781) healthtech.com

2 TABLE OF CONTENTS CONFERENCE SERIES Biological Therapeutic Products... 4 Biomarkers and Diagnostics... 4 Bioprocess and Manufacturing... 4 Clinical Trials & Translational Medicine... 5 Chemistry... 5 BioPharmaceutical Strategy... 6 Drug Discovery & Development... 6 Drug Targets... 7 Genomics... 7 Healthcare... 7 Informatics and IT... 8 Therapeutic Indications... 8 Technology and Tools for Life Sciences... 9 CONFERENCES BY DATE WITH DETAIL SHORT COURSE SCHEDULE About Cambridge Healthtech Institute For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business. For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com. Follow youtube.com/user/cambridgehealthtech linkedin.com/company/cambridge-healthtech-institute CONTACT US CUSTOMER SERVICE Pamela Gerardi Director of Customer Service E: pgerardi@healthech.com T: Kris Waterman Sr. Customer Service Representative E: kwaterman@healthtech.com T: Rose LaRaia Customer Service Representative E: rlaraia@healthtech.com T: MARKETING Jim MacNeil Vice President of Marketing E: jmacneil@healthtech.com T: Rich Handy Senior Director of Marketing E: rhandy@healthtech.com T: SPONSOR & EXHIBIT SALES Angela Parsons Vice President of Business Development E: aparsons@healthtech.com T: Carol Dinerstein Director, Business Development E: dinerstein@healthtech.com T: GROUP SALES David Cunningham Director, Inside Sales E: cunningham@healthtech.com T: GRAPHICS Thomas Norton Design Director E: tnorton@healthtech.com T: PRODUCTION Edel O Regan, Ph.D. Vice President of Production E: eoregan@healthtech.com T: Christina Lingham Executive Director of Conferences E: clingham@healthtech.com T: Mary Ann Brown Executive Director of Conferences E: mabrown@healthtech.com T: Julia Boguslavsky Executive Director of Conferences E: juliab@healthtech.com T: Micah Lieberman Executive Director of Conferences E: mlieberman@healthtech.com T: Cambridge Healthtech Institute Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA T: (781) or Toll-free in the U.S F: (781)

3 KEY EVENTS 2015 THE BIOPROCESSING SUMMIT August 3-7, 2015 Westin Copley Place Boston, MA BioprocessingSummit.com August 18-20, 2015 Capital Hilton Hotel Washington, DC NextGenerationDx.com August 24-28, 2015 Marriott Long Wharf Hotel Boston, MA ImVacs.com KOREA The Essential Protein Engineering Summit September 1-3, 2015 JW Marriott Seoul Seocho-gu Seoul, Korea PEGSummitKorea.com September 21-24, 2015 Westin Boston Waterfront Boston, MA DiscoveryOnTarget.com EUROPE The Essential Protein Engineering Summit November 2-6, 2015 EPIC SANA Lisboa Hotel Lisbon, Portugal PEGSummitEurope.com 2016 The Protein Science Week Summit for Clinical Trials Operations Execs January 18-22, 2016 Town and Country Resort & Convention Center San Diego, CA CHI-PepTalk.com February 22-25, 2016 Hyatt Regency Miami Miami, FL SCOPESummit March 6-11, 2016 Miscone North Convention Center San Francisco, CA TriConference.com CHINA The Essential Protein Engineering Summit April 5-7, 2016 Jin Mao Tower Pudong, Shanghai, China PEGSummitChina.com April 5-7, 2016 Seaport World Trade Center Boston, MA Bio-ITWorldExpo.com Drug Discovery Chemistry April 19-22, 2016 Hilton San Diego Resort San Diego, CA DrugDiscoveryChemistry.com BOSTON The Essential Protein Engineering Summit April 25-29, 2016 World Trade Center Boston, MA PEGSummit.com BIOMARKERS & DIAGNOSTICS WORLD CONGRESS May 17-19, 2016 Philadelphia Downtown Marriott Philadelphia, PA BiomarkerWorldCongress.com June 15-17, 2016 Westin Boston Waterfront Boston, MA WorldPharmaCongress.com August 2015 February 2016 Catalog 3

4 Conferences by Series Biological Therapeutic Products Diagnostics to Guide Cancer Immunotherapy IMVACS: The Immunotherapies & Vaccine Summit August 24-28, 2015 Boston, MA Immunomodulatory Therapeutic Antibodies for Cancer August 24-25, 2015 Boston, MA Novel Vaccines Part I: Adjuvants August 24-25, 2015 Boston, MA Novel Vaccines Part II: Emerging Technologies August 25-26, 2015 Boston, MA Target Discovery for T Cell Therapy August 27-28, 2015 Boston, MA Gene Editing for Immunotherapy August 27-28, 2015 Boston, MA PEGS Korea Sept. 1-3, 2015 Seocho-gu Seoul Korea GPCR-Based Drug Discovery Part 2 Antibodies Against Membrane Protein Targets Part 2 PEGS Europe Summit November 2-6, 2015 Lisbon Portugal Optimization & Development of Biologics November 2-3, 2015 Lisbon Portugal Display of Antibodies November 2-3, 2015 Lisbon Portugal Protein Purification Technologies November 2-3, 2015 Lisbon Portugal Engineering Expression Systems November 2-3, 2015 Lisbon Portugal Bioreactor Design & Engineering Bispecifics and Novel Biotherapeutics Applying Expression Platforms Protein Aggregates & Particles Bioproduction: Scaling Up & Down Cancer Biotherapeutics Analytical Characterization of Biotherapeutics Protein Formulation & Stability Immunogenicity & Bioassay Summit November 17-19, 2015 Baltimore, MD Immunogenicity Assessment & Clinical Relevance November 17-18, 2015 Baltimore, MD Immunogenicity Prediction & Mitigation November 18-19, 2015 Baltimore, MD Optimizing Bioassays for Biologics November 18-19, 2015 Baltimore, MD PepTalk January 18-22, 2016 San Diego, CA Next Generation Dx Summit August 18-20, 2015 Washington, DC Predictive Cancer Biomarkers Companion Diagnostics Coverage and Reimbursement of Advanced Diagnostics Clinical NGS Assays Molecular Diagnostics for Infectious Disease Enabling Point-of-Care Diagnostics Diagnostics to Guide Cancer Immunotherapy Commercialization of Molecular Diagnostics Clinical Application of Cell-Free DNA Leveraging Pharmacies for Rapid Diagnostics NGS Diagnostics Targeting the Microbiome Targeting Ocular Disorders Kinase Inhibitor Discovery Digital PCR November 2-4, 2015 San Diego, CA Advances in Prenatal Molecular Diagnostics November 16-18, 2015 Boston, MA Diagnostics to Guide Antimicrobial Stewardship and Drug Development Reproductive Genetic Diagnostics November 18-19, 2015 Boston, MA 4 Cambridge Healthtech Institute

5 Conferences by Series The Bioprocessing Summit August 3-7, 2015 Boston, MA Protein Purification Technologies November 2-3, 2015 Lisbon Portugal Bioreactor Design & Engineering Bioproduction: Scaling Up & Down Immunogenicity Assessment & Clinical Relevance November 17-18, 2015 Baltimore, MD Immunogenicity Prediction & Mitigation November 18-19, 2015 Baltimore, MD Optimizing Bioassays for Biologics November 18-19, 2015 Baltimore, MD PepTalk January 18-22, 2016 San Diego, CA GPCR-Based Drug Discovery Part 1 Targeting the Unfolded Protein Response GPCR-Based Drug Discovery Part 2 Quantitative Systems Pharmacology Strategic Resource Management November 2-3, 2015 Philadelphia, PA Portfolio Management November 3-4, 2015 Philadelphia, PA Clinical Development and Commercialization of Antibacterials Immunogenicity & Bioassay Summit November 17-19, 2015 Baltimore, MD Summit for Clinical Ops Executives (SCOPE) February 23-25, 2016 Miami, FL Global Site Selection, Feasibility Assessment, Operations and Site Management February 23-24, 2016 Miami, FL Enrollment Planning and Patient Recruitment February 23-24, 2016 Miami, FL Clinical Trial Forecasting and Budgeting February 23-24, 2016 Miami, FL Implementing Risk-Based Monitoring (Part 1) February 23-24, 2016 Miami, FL Clinical IT Strategy and Governance February 23-24, 2016 Miami, FL Managing Late Stage Research and Observational Studies February 23-24, 2016 Miami, FL Improving Site-Study Activation and Performance February 24-25, 2016 Miami, FL Patient Engagement, Enrollment and Retention through Communities and Technology February 24-25, 2016 Miami, FL Managing Outsourced Clinical Trials February 24-25, 2016 Miami, FL Implementing Risk-Based Monitoring (Part 2) February 24-25, 2016 Miami, FL Clinical Data Technology and Integration February 24-25, 2016 Miami, FL Leveraging Existing Data for Clinical and Observational Research February 24-25, 2016 Miami, FL Discovery on Target September 21-24, 2015 Boston, MA GPCR-Based Drug Discovery Part 1 Targeting Epigenetic Readers and Chromatin Remodelers Kinase Inhibitor Discovery Targeting the Unfolded Protein Response GPCR-Based Drug Discovery Part 2 Targeting Histone Methyltransferases and Demethylases August 2015 February 2016 Catalog 5

6 Conferences by Series Companion Diagnostics Coverage and Reimbursement of Advanced Diagnostics Strategic Resource Management November 2-3, 2015 Philadelphia, PA Portfolio Management November 3-4, 2015 Philadelphia, PA Clinical Development and Commercialization of Antibacterials Summit for Clinical Ops Executives (SCOPE) February 23-25, 2016 Miami, FL IMVACS-The Immunotherapies & Vaccine Summit August 24-28, 2015 Boston, MA Immunomodulatory Therapeutic Antibodies for Cancer August 24-25, 2015 Boston, MA PEGS Korea Sept. 1-3, 2015 Seoul Korea Discovery on Target September 21-24, 2015 Boston, MA New Frontiers in Gene Editing GPCR-Based Drug Discovery Part 2 Targeting Histone Methyltransferases and Demethylases Antibodies Against Membrane Protein Targets Part 2 Targeting the Microbiome Targeting the Unfolded Protein Response Targeting the Ubiquitin Proteasome System RNAi for Functional Genomics Screening GPCR-Based Drug Discovery Part 1 Targeting Epigenetic Readers and Chromatin Remodelers Antibodies Against Membrane Protein Targets Part 1 Gene Therapy Breakthroughs Targeting Ocular Disorders Kinase Inhibitor Discovery Quantitative Systems Pharmacology Optimization & Development of Biologics November 2-3, 2015 Lisbon Portugal Display of Antibodies November 2-3, 2015 Lisbon Portugal Engineering Expression Systems November 2-3, 2015 Lisbon Portugal Bispecifics and Novel Biotherapeutics Applying Expression Platforms Protein Aggregates & Particles Cancer Biotherapeutics Analytical Characterization of Biotherapeutics Protein Formulation & Stability FAST: Functional Analysis & Screening Technologies Congress November 9-11, 2015 Boston, MA 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models November 9-10, 2015 Boston, MA Phenotypic Drug Discovery November 9-10, 2015 Boston, MA Screening Strategies for Cancer Immunotherapy November 10-11, 2015 Boston, MA Screening and Functional Analysis of 3D Models November 10-11, 2015 Boston, MA Antibacterial Research and Development November 16-17, 2015 Boston, MA Clinical Development and Commercialization of Antibacterials Diagnostics to Guide Antimicrobial Stewardship and Drug Development 6 Cambridge Healthtech Institute

7 Conferences by Series Drug Targets SERIES Discovery on Target September 21-24, 2015 Boston, MA Next Generation Histone Deacetylose Inhibitors Targeting the Microbiome Targeting the Ubiquitin Proteasome System GPCR-Based Drug Discovery Part 1 Targeting Epigenetic Readers and Chromatin Remodelers Antibodies Against Membrane Protein Targets Part 1 Targeting Ocular Disorders Kinase Inhibitor Discovery Targeting the Unfolded Protein Response GPCR-Based Drug Discovery Part 2 Targeting Histone Methyltransferases and Demethylases Antibodies Against Membrane Protein Targets Part 2 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models November 9-10, 2015 Boston, MA Phenotypic Drug Discovery November 9-10, 2015 Boston, MA Screening Strategies for Cancer Immunotherapy November 10-11, 2015 Boston, MA Screening and Functional Analysis of 3D Models November 10-11, 2015 Boston, MA Re- Entering Antibacterial Drug Development Summit November 16-18, 2015 Boston, MA NGS Diagnostics Targeting the Ubiquitin Proteasome System RNAi for Functional Genomics Screening Targeting Epigenetic Readers and Chromatin Remodelers Antibodies Against Membrane Protein Targets Part 1 Gene Therapy Breakthroughs New Frontiers in Gene Editing Targeting Histone Methyltransferases and Demethylases Diagnostics to Guide Antimicrobial Stewardship and Drug Development Reproductive Genetic Diagnostics November 18-19, 2015 Boston, MA Prenatal Molecular Diagnostics November 16-18, 2015 Boston, MA Coverage and Reimbursement of Advanced Diagnostics Reproductive Genetic Diagnostics November 18-19, 2015 Boston, MA Prenatal Molecular Diagnostics November 16-18, 2015 Boston, MA August 2015 February 2016 Catalog 7

8 Conferences by Series Converged IT Summit 2015 Sept. 9-10, 2015 San Francisco, CA Quantitative Systems Pharmacology September 23, 2015 Boston, MA Summit for Clinical Ops Executives (SCOPE) February 23-25, 2016 Miami, FL SERIES Immunomodulatory Therapeutic Antibodies for Cancer August 24-25, 2015 Boston, MA PEGS Korea September 1-3, 2015 Seocho-gu Seoul Korea Discovery on Target September 21-24, 2015 Boston, MA Targeting the Microbiome Targeting the Ubiquitin Proteasome System GPCR-Based Drug Discovery Part 1 Targeting Epigenetic Readers and Chromatin Remodelers Gene Therapy Breakthroughs Targeting Ocular Disorders Kinase Inhibitor Discovery Targeting the Unfolded Protein Response GPCR-Based Drug Discovery Part 2 Targeting Histone Methyltransferases and Demethylases Screening Strategies for Cancer Immunotherapy November 10-11, 2015 Boston, MA Antibacterial Research and Development November 16-17, 2015 Boston, MA Clinical Development and Commercialization of Antibacterials Diagnostics to Guide Antimicrobial Stewardship and Drug Development LIFE SCIENCE MEDIA LIBRARY Continue Your Education with CHI s Digital Courses Navigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI s Life Science Media Library to view over 120 digital courses recorded at our most successful events. Formats available: Digital Download On Demand DVD Order Today Healthtech.com/MediaLibrary 8 Cambridge Healthtech Institute

9 Next Generation Dx Summit Clinical NGS Assays Clinical Application of Cell-Free DNA Leveraging Pharmacies for Rapid Diagnostics NGS Diagnostics Novel Vaccines Part II: Emerging Technologies August 25-26, 2015 Boston, MA Gene Editing for Immunotherapy August 27-28, 2015 Boston, MA Converged IT Summit 2015 Sept. 9-10, 2015 San Francisco, CA Discovery on Target September 21-24, 2015 Boston, MA Targeting the Ubiquitin Proteasome System RNAi for Functional Genomics Screening Targeting Epigenetic Readers and Chromatin Remodelers Antibodies Against Membrane Protein Targets Part 1 Gene Therapy Breakthroughs Targeting the Unfolded Protein Response New Frontiers in Gene Editing GPCR-Based Drug Discovery Part 2 Targeting Histone Methyltransferases and Demethylases Antibodies Against Membrane Protein Targets Part 2 Quantitative Systems Pharmacology Protein Aggregates & Particles Analytical Characterization of Biotherapeutics FAST: Functional Analysis & Screening Technologies Congress November 9-11, 2015 Boston, MA 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models November 9-10, 2015 Boston, MA Phenotypic Drug Discovery November 9-10, 2015 Boston, MA Screening Strategies for Cancer Immunotherapy November 10-11, 2015 Boston, MA Sensors Global Summit November 10-11, 2015 La Jolla, CA Screening and Functional Analysis of 3D Models November 10-11, 2015 Boston, MA Diagnostics to Guide Antimicrobial Stewardship and Drug Development Immunogenicity Assessment & Clinical Relevance November 17-18, 2015 Baltimore, MD Immunogenicity Prediction & Mitigation November 18-19, 2015 Baltimore, MD Optimizing Bioassays for Biologics November 18-19, 2015 Baltimore, MD PepTalk January 18-22, 2016 San Diego, CA Practical Applications of NMR in Industry (PANIC) February 16-18, 2016 Houston, TX ONE STOP SHOP AFFILIATED REPORTS COLLECTION for Over 1,000 Life Science Reports Spanning over 50 Research Areas An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports. Insight Pharma Reports offers: 4 Market Data 4 Market Research 4 Pipeline Data 4 Custom Reports 4 Clinical Trial Data 4 Bundled Report Packages For more information, contact Kerri Kelley at: KKelley@InsightPharmaReports.com or call (781) InsightPharmaReports.com Just some of the Reports Available Include: Alzheimer s Disease Biomarkers & Diagnostics BioPharma Strategy Biosimilars & Generic Markets Cancer Research and Therapeutics Chemistry Clinical Trials & Translational Medicine Data Mining Drug Discovery & Development Health IT Infectious Disease Medical Devices Multiple Sclerosis Ocular Pain Management Pharmaceutical Marketing Sequencing Vaccines...and many others August 2015 February 2016 Catalog 9

10 Conferences by Date with Detail The Bioprocessing Summit August 3-7, 2015 Boston, MA The 2015 Bioprocessing Summit plans to unite 750+ attendees from 30+ countries for five days of inspiring presentations and solutions. The Bioprocessing Summit brings together international leaders to discuss today s bioprocess issues from cell line selection to manufacturing. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer. Hundreds of bioprocess professionals come together each year at the Summit to share practical solutions for today s bioprocess challenges with researchers from around the world. Spanning five days, the 2015 meeting includes 12 conference programs, 8 training seminars and 10 short courses. BioprocessingSummit.com Next Generation Dx Summit August 18-20, 2015 Washington, DC The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cellfree DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field. NextGenerationDx.com ImVacS: Immunotherapy and Vaccine Summit August 24-28, 2015 Boston, MA Cambridge Healthtech Institute is pleased to bring you the Tenth Annual ImVacS: Immunotherapy and Vaccine Summit. From its beginnings as a lone adjuvants conference, ImVacS has grown to a multi-track event spanning vaccines, immunotherapies, and platform technologies. This year s event has been expanded to five days with coverage on adjuvants, vaccine and immunotherapy technologies, immunomodulatory therapeutic antibodies for cancer, combination cancer immunotherapy, and T cell target discovery. ImVacS 2015 promises to be a must-attend event for commercial and academic entities to continue advancing immunotherapies and vaccines through technology and innovation. ImVacs.com 10 Cambridge Healthtech Institute PEGS Summit Korea September 1-3, 2015 Seocho-gu Seoul Korea PEGS is CHI s flagship biologics meeting, and is widely considered the industry s leading event on protein and antibody engineering. Its successful accolades include an annual attendance of over 1,800 participants at the PEGS Summit in Boston, a record attendance of over 500 attendees at PEGS Europe last year, a successful launch of PEGS China in 2014, and now, we proudly announce PEGS Korea. This three-day inaugural event will bring together an international faculty of scientists, professors and managers from leading universities, research laboratories and biopharmaceutical companies to share practical applications and case examples in protein and antibody engineering and novel biotherapeutics development. PEGSummitKorea.com Converged IT Summit September 9-10, 2015 Boston, MA September 9-10, 2015 San Francisco, CA This two-day Summit will cover a broad range of topics that will frame the issues behind creating computational solutions for modern research methodologies. Topics will include: technologies currently in use, how organizations are using them to accelerate discovery, efforts that have worked and those that have failed, organizational challenges and policies for research computing, and the art of converged infrastructure as a research tool. ConvergedITSummit.com Discovery on Target September 21-24, 2015 Boston, MA The13th Annual Discovery on Target event showcasing current and emerging hot targets for the pharmaceutical industry will span five days, and attracts 1,000+ attendees (from 21 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2015 the event is comprised of 15 conference tracks, 3 Symposia, 14 short courses, 35+ interactive breakout discussion groups, an exhibit hall of 65 companies, and dedicated poster viewing and networking sessions. The 13th Annual Discovery on Target event assembles an impressive group of 200+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees. DiscoveryOnTarget.com

11 Conferences by Date with Detail Digital PCR November 2-4, 2015 San Diego, CA Polymerase chain reaction (PCR) is an invaluable tool for nucleic acid detection and quantification. As a staple in diagnostics labs, PCR has continued to evolve with scientific need, the latest iteration being digital PCR (dpcr). dpcr increases sensitivity, specificity, and in many cases allows higher throughput. Cambridge Healthtech Institute s Fourth Annual Digital PCR conference will continue to highlight the importance PCR advances for clinical diagnostics. As always, this event gathers technology providers, early adopters, and platform newcomers to network and discuss digital PCR s capabilities, limitations, and future applications. This year, key focus will be placed on the technology behind dpcr, interfacing between dpcr and NGS, and emerging technologies and areas of study. Other topics to be addressed include solutions for processing difficult samples and increasing sample throughput, working with extracellular DNA, and guidelines and best practices for digital detection. Healthtech.com/Digital-PCR Strategic Resource Management November 2-3, 2015 Philadelphia, PA Although investment in pharma R&D continues to increase, approval of new drugs remains relatively low. This productivity crisis presents new challenges to biopharma R&D in terms of resource management, forecasting, and capacity planning. To counteract the decline in new therapeutics and high risk of product failure, biopharma must adapt with improved performance planning, intelligent outsourcing, and new big data analytics aimed at developing strategic and flexible resource management systems. The 13th Annual Strategic Resource Management: Enhanced R&D Productivity, Forecasting and Planning, attracts over 100 senior R&D executives sharing best practices and new ideas on how to enhance R&D productivity, forecasting and planning with important discussions on optimizing resource management, outsourcing, innovation, R&D, clinical capacity planning, forecasting and business intelligence strategies. ExecutiveDecisionMaking.com/ResourceManagement Portfolio Management November 3-4, 2015 Philadelphia, PA In an environment of declining revenues and uncertain commercial success, biopharma, device and R&D companies need to continuously evaluate their portfolios. Manufacturers must make tough decisions about which products and projects to pursue to optimize long-term revenue and reduce overall risk. The 10th Annual Portfolio Management: Aligning Portfolio and Productivity with Corporate Strategy to Drive Innovation attracts over 100 senior R&D executives from the pharma, biotech, device, IT, public and governmental communities who share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting and the improvement of operational models. Effective portfolio management requires the alignment of portfolio and productivity with corporate strategy, supporting agile development and adaptation of data into planning. ExecutiveDecisionMaking.com/PortfolioManagement PEGS Europe Summit November 2-6, 2015 Lisbon, Portugal PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With three consecutive years of 35% growth in attendance, and another year of expanded program coverage, this year s event will feature 700 attendees, 200 technical presentations, 150 scientific posters, dedicated networking opportunities, exclusive exhibit & poster viewing hours, and interactive roundtable, breakout & panel discussions. PEGSummitEurope.com FAST: Functional Analysis & Screening Technologies November 9-11, 2015 Boston, MA With the tremendous expense of bringing new drugs to market, a focus on improving the outcome of first-stage research is critical. Recent evidence confirms the need for innovative screening systems utilizing assay design on three-dimensional tissue models and phenotypic models. This functional analysis will allow for more accurate biological response. Cambridge Healthtech Institute is pleased to introduce FAST: Functional Analysis & Screening Technologies Congress to bring together drug research and development teams for practical discussion, solutions and case studies for refining these first-stage drug discovery methods. FastCongress.com August 2015 February 2016 Catalog 11

12 Conferences by Date with Detail Advances in PreNatal Molecular Diagnostics November 18-19, 2015 Boston, MA The growing acceptance and availability of NIPT, based on next-gen sequencing of cell-free DNA from maternal blood, is having a dramatic impact on prenatal testing. One result has been the steady decline in the number of women choosing invasive testing, with growing replacement of karyotyping by arrays or in some cases sequencing for analysis of these samples. For non-invasive testing there has been increased differentiation among the leading test service providers. There has been a push to expand NIPT use beyond higher-risk pregnancies, as well as extending the range of genetic conditions reported from the tests, but such changes come at a price. Testing based on isolation of fetal cells from maternal blood would provide an attractive alternative to testing of cell-free DNA, but the commercialization of this approach has faced a range of challenges. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration. HealthTech.com/Prenatal-Diagnostics Reproductive Genetic Diagnostics November 18-19, 2015 Boston, MA Rapidly evolving technologies are transforming the way reproductive genetic diagnostics and screening are performed, but the differences, limitations, and benefits of these new technologies remain unclear to some. The Inaugural Reproductive Genetic Diagnostics conference aims to examine the latest technologies, including nextgeneration sequencing (NGS), quantitative PCR, and long fragment read (LFR), and their benefits and applications in carrier screening, preimplantation diagnostics, and product of conception (POC) testing. As these technologies develop and become widespread, we must understand their capabilities, where each technology is best applied, and be sure that they have been analytically and clinically validated. Furthermore, as the technology outpaces practices, we must take a critical eye to the ethical implications of the applications of these technologies, including the regions of the genome that should be sequenced and the types and amount of sequence variation that is necessary for diagnosis. Join this event with your colleagues to meet with clinicians, researchers, developers, and key thought leaders and to examine these topics. HealthTech.com/Reproductive-Genetic-Diagnostics Re-Entering Antibacterial Drug Development Summit November 16-18, 2015 Boston, MA According to the Centers for Disease Control and Prevention, antibiotic-resistant infections are associated with an additional 23,000 deaths and 2 million illnesses in the United States each year. The estimated annual impact of antibiotic-resistant infections on the national economy is $20 billion in excess direct health care costs, and as much as $35 billion in lost productivity from hospitalizations and sick days. By holding the Second Annual Re-Entering Antibacterial Drug Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to revive antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development. HealthTech.com/Antibacterial-Drug-Development Immunogenicity and Bioassay Summit November 17-19, 2015 Baltimore, MD Since 2009, CHI s Annual Immunogenicity and Bioassay Summit event has gone from strength-to-strength. We always have wonderful input from the regulatory agencies in the form of presentations, breakout discussion leaders and audience participation resulting in intense and lively discussion to help attendees sort out their regulatory challenges. By running Immunogenicity Assessment and Clinical Relevance back-to-back with Optimizing Bioassays for Biologics we provide Directors and Scientists in Bioanalytical Sciences and Assay Development with 30+ presentations spread over 3 days. Immunogenicity Assessment and Clinical Relevance is also back-to-back with Immunogenicity Prediction and Mitigation to provide 3 days and 30+ presentations focusing purely on Immunogenicity. We offer 45 + presentations of case studies and advice form the experts, a choice of 15+ breakout discussions, many posters and an exciting exhibition. This event addresses all the key issues and challenges in Immunogenicity and Bioassays to ensure your product is safe and efficacious in the clinic. We look forward to seeing you at the event. ImmunogenicitySummit.com 12 Cambridge Healthtech Institute

13 Conferences by Date with Detail PepTalk: The Protein Science Week January 18-22, 2016 Boston, MA PepTalk: The Protein Science Week is one of the largest gatherings of protein science researchers in the United States. It offers an array of education, innovation and networking programs, and provides many opportunities to scientists. PepTalk is an annual gathering where industry experts from around the world convene to share case studies, unpublished data, breakthroughs and solutions that support and enhance research, and to gain new perspectives on the evolution of biologics. CHI-Peptalk.com High-Content Analysis & Phenotypic Screening February 11-12, 2016 San Diego, CA CHI s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The High-Content Analysis meeting will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Second Annual Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma. Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and an offering of user group meetings and dinner courses. HighContentAnalysis.com PANIC: Practical Applications of NMR in Industry February 15-18, 2016 Houston, TX The PANIC meeting is intended to address topics that occur daily in industrial, government, and academic research laboratories whose primary task entails the application of NMR to a diverse set of analytical problems. Topics include quantitation, molecular structure characterization, trace component and mixture analysis, and product support for a variety of materials that include small molecules, polymers, heterogeneous mixtures, natural products, biosimilars, polysaccharides, and proteins. The conference provides in-depth discussions of the nuts and bolts of basic NMR experiments that accent the underlying bestpractices developed to address these everyday problems. It also explores the regulatory aspects of the applications of these experiments. Greater insights will be provided into the less frequently explored techniques used in NMR such as quantitation, chemometrics, automation, relaxometry, and low-field instrumentation. Attendees will have the opportunity to learn about and discuss applications of NMR to pharmaceuticals, polymers, petroleum, food/agriculture, and plant production that are rarely discussed at other NMR meetings. Ample opportunity will be given to network with people who are experts in inventing NMR experiments to solve real world problems in a timely and efficient manner that is demanded by working in the venue of product delivery. PanicNMR.com SCOPE: Summit for Clinical Trials Operations Executives February 22-25, 2016 Miami, FL The 7th Annual SCOPE Summit, taking place February 23-25, 2016 in Miami, FL, will offer three stimulating days of in-depth discussions in 12 different conferences, 4 pre-conference workshops and 2 symposia focused on issues related to each aspect of clinical trial planning and management: Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials. SCOPESummit.com August 2015 February 2016 Catalog 13

14 Short Course Schedule HOLD A COURSE AT YOUR FACILITY. For more information, please contact Edel O Regan at or eoregan@healthtech.com Short Course Title Optimizing Media: Achieving Super Soup Conference / Date / Location THE BIOPROCESSING SUMMIT August 3, 2015 Boston, MA Biophysical Characterization in Assessing the Higher Order Structure (HOS) Fingerprint of Biopharmaceuticals Accelerated Stability Testing of Biologics Analytical Strategies for Comparability in Bioprocess Development Operational Excellence Strategies for Bioprocessing QbD, DoE and PAT Protein Aggregation: Mechanism, Characterization and Consequences Patent Strategies for Bioprocess Scientists Incorporating the Concepts of Pharmaceutical Quality Systems into Cell Therapy Products Transient Protein Production in Mammalian Cells ABC: Anything But Chromatography Precipitation, Crystallization and Flocculation Use of FFPE/Fixed Tissues for Clinical Research Method Validation According to CLSI Guidelines Practical Considerations for NGS Data Analysis and Interpretation Biomarkers for Cancer Immunotherapy Microfluidics for Point-of-Care Establishing the Value of Diagnostic Tests NGS as a Diagnostics Platform Detection and Characterization of Circulating Biomarkers Regulatory Compliance in Molecular Diagnostics Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies NGS for Infectious Disease Diagnostics Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays Targeting the Cancer Mutanome Adoptive Therapy with Car T Cells Cancer Metabolism: Pathways, Targets and Clinical Updates Leveraging Data and Analytics for Drug Discovery Setting up Effective RNAi Screens: From Design to Data to Validation Phenotypic Screening and Chemical Probe Development GPCR Structure-Based Drug Discovery Targeting of GPCRs with Monoclonal Antibodies Setting Up Effective Functional Screens Using 3D Cell Cultures Targeting Protein-Protein Interactions: Biophysical Approaches Preclinical Animal Models for Ocular Indications Introduction to Allosteric Modulators and Biased Ligands of GPCRs Introduction to Targeted Covalent Inhibitors Assays and High-Throughput Screening for Novel Epigenetic Inhibitors Gamification and Drug Target Challenges A Primer to Gene Editing: Tools and Applications Using Mechanistic Physiological Models in Drug Development: A Proven Quantitative Systems Pharmacology (QSP) Approach Digital PCR: A Technology Primer August 3, 2015 Boston, MA August 3, 2015 Boston, MA August 4, 2015 Boston, MA August 4, 2015 Boston, MA August 4, 2015 Boston, MA August 4, 2015 Boston, MA August 4, 2015 Boston, MA August 6, 2015 Boston, MA August 6, 2015 Boston, MA NEXT GENERATION DX SUMMIT August 19, 2015 Washington, DC August 19, 2015 Washington, DC August 19, 2015 Washington, DC IMVACS: IMMUNOTHERAPY AND VACCINE SUMMIT August 25, 2015 Boston, MA August 27, 2015 Boston, MA DISCOVERY ON TARGET September 23, 2015 Boston, MA September 23, 2015 Boston, MA September 23, 2015 Boston, MA September 23, 2015 Boston, MA September 23, 2015 Boston, MA September 23, 2015 Boston, MA DIGITAL PCR November 2, 2015 San Diego, CA 14 Cambridge Healthtech Institute

15 Short Course Schedule Short Course Title Single-Cell Genomic Analysis Engineering of Bispecific Antibodies CHO Cell Engineering Protein Purification Strategies: Dealing with Proteins that are Prone to Aggregate Mutation and Selection Strategies for Multi-Parameter Antibody Optimization In Silico Antibody Design with BioLuminate Troubleshooting and Engineering of Antibody Constructs The Challenge of Protein Aggregation and Formation of Sub Visible Particles in the Development of Biopharmaceuticals Advanced Techniques for Characterization of Protein Aggregates, Particulates and Contaminants Immunotherapy in the 21st Century: More Specificity, More Potency, Better Targeting Project Portfolio Management Certification Master Class Introduction to High-Content Phenotypic Screening Exploring 3D Printing, Bioinks and Scaffolds Stem Cell Models for Drug Discovery Engineering Microfluidic Cell Culture Chips How to Meet the Need for Physiologically-Relevant Assays Basics of Immunogenicity Testing Challenges of Immunogenicity Assessment Immunogenicity Risk Assessment and Regulatory Strategy Strategic Bioassay Design and Analysis Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins A Rational Approach to Formulation Development of Biologic Therapeutics Genome Editing Using CRISPR Accelerated Stability Testing of Biologics Establishing the Business Case for Single-Use and Continuous Processing Targeting of GPCRs with Monoclonal Antibodies Affecting Effector Function: Engineering the Fc Region Protein Aggregation: Mechanism, Characterization and Consequences Transient Protein Production in Mammalian Cells Materials in Contact with Biologics: Understanding Risk to Quality and Safety Protein Purification Strategies: Dealing with Proteins that Are Prone to Aggregate Short Course 1 (Title TBA) Short Course 2 (Title TBA) How to Accelerate Site Selection, Study Activation, and Patient Recruitment for Fast Clinical Trials Short Course 2 (Title TBA) Short Course 3 (Title TBA) Short Course 4 (Title TBA) Conference / Date / Location November 3, 2015 San Diego, CA PEGS EUROPE November 2, 2015 Lisbon, Portugal November 2, 2015 Lisbon, Portugal November 2, 2015 Lisbon, Portugal November 2, 2015 Lisbon, Portugal November 2, 2015 Lisbon, Portugal November 5, 2015 Lisbon, Portugal November 5, 2015 Lisbon, Portugal November 5, 2015 Lisbon, Portugal November 5, 2015 Lisbon, Portugal STRATEGIC RESOURCE MANAGEMENT November 5-6, 2015 Philadelphia, PA FAST CONGRESS: FUNCTIONAL ANALYSIS & SCREENING TECHNOLOGIES TBA Boston, MA TBA Boston, MA TBA Boston, MA TBA Boston, MA TBA Boston, MA IMMUNOGENICITY & BIOASSAY SUMMIT November 16, 2015 Baltimore, MD November 16, 2015 Baltimore, MD November 18, 2015 Baltimore, MD November 18, 2015 Baltimore, MD PEPTALK: THE PROTEIN SCIENCE WEEK January 18, 2016 San Diego, CA January 18, 2016 San Diego, CA January 18, 2016 San Diego, CA January 18, 2016 San Diego, CA January 18, 2016 San Diego, CA January 20, 2016 San Diego, CA January 20, 2016 San Diego, CA January 20, 2016 San Diego, CA January 20, 2016 San Diego, CA January 20, 2016 San Diego, CA January 20, 2016 San Diego, CA HIGH-CONTENT ANALYSIS & PHENOTYPIC SCREENING February 10, 2016 San Diego, CA February 11, 2016 San Diego, CA SCOPE: SUMMIT FOR CLINICAL TRIAL EXECUTIVES TBA Miami, FL TBA Miami, FL TBA Miami, FL TBA Miami, FL August 2015 February 2016 Catalog 15

16 Cambridge Healthtech Institute Your Life Science Network Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA T: (781) or Toll-free in the U.S F: (781) healthtech.com August 2015 February 2016 Catalog 16